Competitive fitness assay data for DMSO and ivermectin.
收藏数据链接：
官方服务：
资源简介：
Competitive fitness assay data for DMSO and ivermectin.
应用场景：
创建时间：
2024-05-20
相关数据集
In Vitro Efficacy of Miltefosine Against Clinical Isolates of Acanthamoeba spp. from Patients with Keratitis
The US Food and Drug Administration (USFDA) granted the miltefosine orphan drug designation in 2016 for treating Acanthamoeba keratitis. This study evaluates miltefosine’s in vitro effic
DataCite Commons2025-09-22 更新40
Half maximal effective concentration (EC 50 ) of raloxifene against Leishmania spp.
aParasite form: P: promastigotes; LA: lesion derived amastigotes; IA: intracelullar amastigotes. Half maximal effective concentration against promastigotes and axenic lesion-derived amastigotes was de
NIAID Data Ecosystem30
Microscopic alterations in Fasciola hepatica from sheep treated with albendazole
Abstract Currently, albendazole is one of the most commonly used drugs because of its affordability. The objective was to evaluate the histopathology of Fasciola hepatica specimens. For this, the eff
NIAID Data Ecosystem20
In vitro drug susceptibility of a panel of recent clinical L . infantum isolates against antileishmanial reference drugs in THP-1, bone-marrow derived macrophages (BMMφ) and mouse peritoneal exudative cells (PEC).
Intracellular amastigote drug susceptibility against miltefosine (MIL), paromomycin (PMM), pentavalent antimonials (SbV), trivalent antimonials (SbIII) and amphotericin B (AmB). The presented IC50-val
NIAID Data Ecosystem40
Additional file 1 of Efficacy of afoxolaner (NexGard®) against natural infestations with Trichodectes canis in dogs under field conditions
Additional file 1: Table S1. Dataset representing all the collected data and the results of the periodical checking’s.
NIAID Data Ecosystem20
